Reimagining early-stage drug discovery leveraging NVIDIA BioNeMo FrameworkSANTA CLARA, Calif. and PUNE, India, March 17, 2026 /PRNewswire/ -- Persistent Systems (BSE: 533179) (NSE: PERSISTENT) ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
According to a stock exchange filing, the digital engineering leader has launched a Generative Molecules and Virtual ...
Persistent Launches AI-Powered Generative Molecules and Virtual Screening Solution Powered by NVIDIA
Persistent Systems, a global Digital Engineering and Enterprise Modernization leader, today announced it is working with NVIDIA to accelerate the development and deployment of AI-powered solutions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results